NP/PA Connect
News
Media
Around the PracticeBetween The LinesCase-Based Peer PerspectiveClinical Case CollectiveDermViewExpert PerspectivesFellows Face OffFrontline ForumMedical World NewsPatient PerspectivesPodcastsReadout360Recognize and Refer
Conferences
Conference CoverageConference Listing
Events
Case-Based Roundtable
More
Publication
Dermatology Times
CME/CE
Resources
DermIQInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • NP/PA Connect
  • News
  • Media
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Non-Melanoma Skin Cancers
  • Vitiligo
  • Wound Care
Advertisement

Todd Edwards

Advertisement

Articles by Todd Edwards

AAD and VStrong Vitiligo Support Community Receive Inaugural Incyte Ingenuity Awards in Vitiligo

ByKaitlyn Bader, Senior Editor ,Todd Edwards
July 11th 2023

Incyte representative Todd Edwards discusses how the awards help address challenges faced by patients with vitiligo.

Advertisement

Latest Updated Articles

  • AAD and VStrong Vitiligo Support Community Receive Inaugural Incyte Ingenuity Awards in Vitiligo
    AAD and VStrong Vitiligo Support Community Receive Inaugural Incyte Ingenuity Awards in Vitiligo

    Published: July 11th 2023 | Updated:



Advertisement
Advertisement

Trending on Dermatology Times

1

Kyowa Kirin Takes Full Control of Rocatinlimab Program

2

Dermatology Times January 2026 Recap

3

Galderma Prioritizes Menopause-Related Skin Health with New Data at IMCAS 2026

4

Phase 2 TYK2 Inhibition Shows Promise in AD

5

Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us